Home » Stocks » ELEV

Elevation Oncology, Inc. (ELEV)

Elevation Oncology will go public soon. The estimated IPO date is June 25, 2021.
Stock Price: $15.00 - $17.00
Current IPO price range
Market Cap 365.16M
Revenue (ttm) n/a
Net Income (ttm) -20.40M
Shares Out 22.82M
EPS (ttm) -0.89
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Elevation Oncology, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About ELEV

Elevation Oncology is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. We utilize our deep expertise in developing drugs for rare, genomically-defined patient populations and strategic collaborations with our diagnostic collaborators to work towards a future where each tumor’s unique genomic test result can be matched with a purpose-built precision medicine. Our lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genom... [Read more...]

Industry
Biological Products
IPO Date
Jun 25, 2021
CEO
Shawn Leland, Pharm.D., R.Ph.
Employees
8
Stock Exchange
NASDAQ
Ticker Symbol
ELEV
Full Company Profile

Financial Performance

Financial Statements